Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Digimarc Corp
DMRC
$169M
| $2.51M | 0.01% |
130,472
+25,500
| +24% | +$491K |
|
1627
Astronics
ATRO
$4.61B
| $2.5M | 0.01% |
107,532
-11,731
| -10% | -$257K |
|
|
SGNT
1628
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.5M | 0.01% |
98,500
+41,900
| +74% | +$946K |
|
|
TSYS
1629
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $2.5M | 0.01% |
1,077,100
-9,600
| -0.9% | -$22.5K |
|
1630
Pebblebrook Hotel Trust
PEB
$2.06B
| $2.5M | 0.01% |
81,200
+54,700
| +206% | +$1.61M |
|
|
TGP
1631
DELISTED
Teekay LNG Partners L.P.
TGP
| $2.49M | 0.01% |
58,400
+29,500
| +102% | +$1.21M |
|
1632
Cheniere Energy
CQP
$33.4B
| $2.49M | 0.01% |
87,000
-103,100
| -54% | -$2.99M |
|
|
GMLP
1633
DELISTED
Golar LNG Partners LP
GMLP
| $2.49M | 0.01% |
82,400
+15,186
| +23% | +$469K |
|
|
BMR
1634
DELISTED
BIOMED REALTY TRUST INC
BMR
| $2.49M | 0.01% |
137,400
-481,400
| -78% | -$9.12M |
|
|
USAK
1635
DELISTED
USA Truck Inc
USAK
| $2.48M | 0.01% |
185,400
+99,200
| +115% | +$1.28M |
|
|
RSYS
1636
DELISTED
Radisys Corp
RSYS
| $2.48M | 0.01% |
1,081,120
-6,680
| -0.6% | -$17.8K |
|
|
LCAV
1637
DELISTED
LCA-VISION INC
LCAV
| $2.48M | 0.01% |
634,800
-15,100
| -2% | -$53.2K |
|
1638
Deere & Co
DE
$164B
| $2.48M | 0.01% |
+27,100
| New | +$2.29M |
|
1639
Dollar Tree
DLTR
$24.9B
| $2.47M | 0.01% |
43,830
+33,630
| +330% | +$1.94M |
|
|
SUNE
1640
SUNation Energy
SUNE
$10.6M
| – | – |
0
| – | – |
|
|
TNH
1641
DELISTED
Terra Nitrogen
TNH
| $2.47M | 0.01% |
17,500
-30,400
| -63% | -$5.42M |
|
|
OME
1642
DELISTED
Omega Protein
OME
| $2.46M | 0.01% |
200,100
+108,500
| +118% | +$1.27M |
|
|
WW
1643
DELISTED
WW International
WW
| $2.46M | 0.01% |
+74,612
| New | +$2.6M |
|
|
AIFU
1644
AIFU Inc
AIFU
$215M
| $2.46M | 0.01% |
1,016
+132
| +15% | +$272K |
|
|
BFIN
1645
DELISTED
BankFinancial
BFIN
| $2.45M | 0.01% |
267,900
+1,700
| +0.6% | +$15.7K |
|
1646
Citi Trends
CTRN
$616M
| $2.45M | 0.01% |
144,250
-20,775
| -13% | -$337K |
|
|
GPT
1647
DELISTED
Gramercy Property Trust
GPT
| $2.45M | 0.01% |
142,160
+51,667
| +57% | +$760K |
|
|
MSFG
1648
DELISTED
MainSource Financial Group Inc
MSFG
| $2.45M | 0.01% |
135,900
+13,300
| +11% | +$218K |
|
|
CCSC
1649
DELISTED
COUNTRY STYLE COOKING RESTAURANT CHAIN CO LTD ADS CAYMAN ISL
CCSC
| $2.44M | 0.01% |
242,600
+14,500
| +6% | +$145K |
|
|
SRT
1650
DELISTED
Startek Inc.
SRT
| $2.44M | 0.01% |
375,400
+13,900
| +4% | +$88K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.